Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S DeVito

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Medicine and Philosophy|October 18, 2000
On the value-neutrality of the concepts of health and disease: unto the breach againS DeVito
Journal of the Air & Waste Management Association (1995)|January 13, 2017
Interlaboratory and Intralaboratory Variability in the Analysis of Mercury in CoalJohn Lengyel, Matthew S DeVito, Richard A Bilonick
Advances in Experimental Medicine and Biology|January 1, 1996
Electronic models for cytochrome P450 oxidationsK R Korzekwa, J Grogan, S DeVito, et al.
Abdominal Imaging|May 1, 2008
CT enterography vs. capsule endoscopyHoward S Boriskin, Bethany S Devito, John J Hines, et al.
Military Medicine|November 6, 2015
Control of Junctional Hemorrhage in a Consensus Swine Model With Hemostatic Gauze Products Following Minimal TrainingSean P Conley, Lanny F Littlejohn, Jose Henao, et al.
Regulatory Toxicology and Pharmacology : RTP|January 22, 2015
Hazard assessment of nitrosamine and nitramine by-products of amine-based CCS: alternative approachesH E Buist, S Devito, R A Goldbohm, et al.
Regulatory Toxicology and Pharmacology : RTP|January 28, 2014
WITHDRAWN: Hazard assessment of nitrosamine and nitramine by-products of amine-based CCS: an alternative approachH E Buist, R A Bausch-Goldbohm, S Devito, et al.
The Journal of Emergency Medicine|April 23, 2013
Terlipressin with limited fluid resuscitation in a swine model of hemorrhageJohn J Devlin, Sara S DeVito, Lanny F Littlejohn, et al.
American Heart Journal|December 1, 2012
Optimized duration of clopidogrel therapy following treatment with the Endeavor zotarolimus-eluting stent in real-world clinical practice (OPTIMIZE) trial: rationale and design of a large-scale, randomized, multicenter studyFausto Feres, Ricardo A Costa, Deepak L Bhatt, et al.
JAMA|November 2, 2013
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trialFausto Feres, Ricardo A Costa, Alexandre Abizaid, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Medicine and Philosophy|October 18, 2000
On the value-neutrality of the concepts of health and disease: unto the breach againS DeVito
Journal of the Air & Waste Management Association (1995)|January 13, 2017
Interlaboratory and Intralaboratory Variability in the Analysis of Mercury in CoalJohn Lengyel, Matthew S DeVito, Richard A Bilonick
Advances in Experimental Medicine and Biology|January 1, 1996
Electronic models for cytochrome P450 oxidationsK R Korzekwa, J Grogan, S DeVito, et al.
Abdominal Imaging|May 1, 2008
CT enterography vs. capsule endoscopyHoward S Boriskin, Bethany S Devito, John J Hines, et al.
Military Medicine|November 6, 2015
Control of Junctional Hemorrhage in a Consensus Swine Model With Hemostatic Gauze Products Following Minimal TrainingSean P Conley, Lanny F Littlejohn, Jose Henao, et al.
Regulatory Toxicology and Pharmacology : RTP|January 22, 2015
Hazard assessment of nitrosamine and nitramine by-products of amine-based CCS: alternative approachesH E Buist, S Devito, R A Goldbohm, et al.
Regulatory Toxicology and Pharmacology : RTP|January 28, 2014
WITHDRAWN: Hazard assessment of nitrosamine and nitramine by-products of amine-based CCS: an alternative approachH E Buist, R A Bausch-Goldbohm, S Devito, et al.
The Journal of Emergency Medicine|April 23, 2013
Terlipressin with limited fluid resuscitation in a swine model of hemorrhageJohn J Devlin, Sara S DeVito, Lanny F Littlejohn, et al.
American Heart Journal|December 1, 2012
Optimized duration of clopidogrel therapy following treatment with the Endeavor zotarolimus-eluting stent in real-world clinical practice (OPTIMIZE) trial: rationale and design of a large-scale, randomized, multicenter studyFausto Feres, Ricardo A Costa, Deepak L Bhatt, et al.
JAMA|November 2, 2013
Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trialFausto Feres, Ricardo A Costa, Alexandre Abizaid, et al.
Pageof 2